Drugs + Money
Opvee, High-Profile Overdose Antidote No One Used, Discontinues Marketing
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical ...
Landmark Deals Drop New Injectable PrEP From $28,000 to $40—for Some
Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with ...
Feds Crack Down on TV Drug Ads, in Major Shakeup to Pharma Industry
The era of direct-to-consumer (DTC) pharmaceutical commercials may be coming to a close. On ...
DHS Doesn’t Collect Mandatory Data on Efficacy of Fentanyl Seizures
The Department of Homeland Security (DHS) never created a mandatory data collection program to ...
Trump Begins Deploying US Military to Fight the Drug War
On August 19, United States warships set course for Venezuela. They’ve been deployed there ...
EU Plan to Heavily Tax Safer Substitutes for Cigarettes Draws Fire
The European Union is looking to impose heavy and unprecedented bloc-wide taxes on safer ...
“An Architect of the Crisis”: WV Sues Express Scripts Over Rx Opioids
West Virginia Attorney General J.B. McCuskey (R) has filed a lawsuit against Express Scripts ...
Baltimore Accepts Offer for Fraction of the Opioid Settlement It Sought
The city of Baltimore has opted to take a court deal that will leave ...
Judge Offers Baltimore $100 million for OD Crisis—Far Less Than City Sought
A judge has offered Baltimore $100 million for opioid abatement efforts in a landmark ...
Questions Over Wisconsin Spending of Opioid Settlement Money
Under the nationwide legal settlements with major opioid manufacturers and distributors, the state of ...
